Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-06-25

FDA Approved: FLUOXETINE — Supplemental Application (QUALLENT PHARMACEUTICALS HEALTH LLC)

View source ↗

Summary

FDA approved a supplemental application for fluoxetine hydrochloride (fluoxetine) from QUALLENT PHARMACEUTICALS HEALTH LLC, updating the approved ANDA product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluoxetine (Fluoxetine)

Snippet

SUPPL AP for FLUOXETINE (FLUOXETINE HYDROCHLORIDE)